Implementation of Machine Learning Algorithm for Computer-aided Diagnosis of Indeterminate Pulmonary Lesions on Low-dose CT Imaging
Recent advancements include a risk-stratifying model developed by medical experts and several cutting-edge artificial intelligence machine learning (ML) algorithms that have achieved AUC (area under the receiver operating characteristic curve) as high as 0.896 in assessing the malignancy of all screening-detected abnormalities, underscoring the persistent challenges in effectively resolving IDLs. We hypothesize that the primary difficulty stems from a lack of consideration by these current image-based ML algorithms and expert interpretations concerning how the in vivo tissues of lesions interact with the energy from imaging devices and how the images are made from the collected energy signals or data. To address these challenges, this project seeks to develop an expert-driven ML (EdML) system that integrates tissue biology and other relevant prior knowledge into image assessments for lesion diagnosis via the specific aim (SA) outlined below.
(SA1): Integrating tissue biology to extract pathological characteristic features from medical images for predicting lesion malignancy: This aim focuses on the transformation of in vivo tissues from normal to abnormal states. Utilizing established knowledge about how imaging device energies interact with the tissues to generate image contrasts, we will compute or extract baseline tissue characteristic features from images of normal tissues. Deviations in these features from patient images compared to the baseline will indicate changes from normal tissue states. Using tissue pathology as the definitive ground truth for machine learning labels, these variations can be quantitatively predicted as indicators of lesion malignancy. Preliminary experimental studies utilizing IDL data have shown that our approach can significantly increase the AUC from the typical 0.70s of current image-based ML algorithms up to 0.98. This novel tissue-based ML model, along with its innovative implementation strategies, called EdML system, will be thoroughly investigated and evaluated.
Jacob Gordon, Stony Brook Medicine
Ilan Pesselev, Stony Brook Medicine
Ankit Dhamija, Stony Brook Medicine
Jerome Liang, Stony Brook Medicine